Bone mineral density and prolactin associations in patients with chronic schizophrenia

Schizophrenia Research

Volumn 59, Issue 1, 2003, Pages 17-18

  Abraham, George ^a,e   Halbreich, Uriel ^b   Friedman, Ronald H ^c   Josiassen, Richard C ^d  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Norristown State Hospital   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR; FRACTURE; HUMAN; LUMBAR SPINE; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; TESTOSTERONE BLOOD LEVEL;

EID: 0037209929     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00321-8     Document Type: Letter

References (4)

1. Chavassieux P., Meunier P.J. Mechanisms of bone loss in osteoporosis. Rev. Prat. 45(9):1995;1083-1088.
2. Coss D., Yang L., Kuo C.B., Xu X., Luben R.A., Walker A.M. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am. J. Physiol.: Endocrinol. Metab. 279(6):2000;1216-1225.
3. Klibanski A., Neer R., Beitins I.Z., Ridgway E.C., Zervas N.T., McArthur J.W. Decreased bone density in hyperprolactinemic women. N. Engl. J. Med. 303:1980;1511-1514.
4. Schlechte J.A., Sherman B., Martin R. Bone density in amenorrhoeic women with and without hyperprolactinemia. J. Clin. Endocrinol. Metab. 56:1983;1120-1123.